BioAesthetics

BioAesthetics transforms lives through advancements in biomaterials.

Funding reportedLast round: Convertible Note

BiopharmaDurham, United States

What company datasets say BioAesthetics raised

Funding, as reported

Reported in all$5.0Min dollars

Last roundConvertible Note

Last round dateSept 2023

From BioAesthetics's own website and the SEC filings it signed: 3 on the team.

On the board, as filediSandra I. CoufalYi Sue Gu

AdvisersLaura Bosworth

Investors who name them

Each firm lists BioAesthetics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Startups like it

Add your raise, your deck and your story, and put BioAesthetics in front of investors. Or tell us what we have wrong.